Older Patients Are Choosing Cannabis To Treat Chronic Pain, Arthritis, Anxiety And Insomnia, New Study Shows
Older patients comprise a growing subset of medical marijuana patients, according to a new study.
Titled “Age-related Patterns of Medical Cannabis Use: A Survey of Authorized Patients in Canada,” the new scientific publication presents the consumption trends observed in patients and the self-reported impacts of medical cannabis in alleviating their primary symptoms.
Tilray Medical, a division of Tilray Brands, Inc. (NASDAQ:TLRY) (TSX:TLRY) is behind the study which is derived from the Canadian Cannabis Patient Survey (CCPS) 2021 and included 2,697 patients. Researchers focused primarily on older patients with a mean age of 54.3.
Patients with chronic pain (27.8%), arthritis (14.9%) and anxiety (9%) were the most numerous among those seeking cannabis to treat their primary illnesses.
Pain was the most common primary symptom for which patients use medical cannabis, followed by anxiety and insomnia/sleep disorder.
Nearly 54% of patients taking prescription opioids, reported a decrease in use over the past year with medical cannabis.
This and other scientific breakthroughs in the cannabis space will undoubtedly be discussed at the upcoming Benzinga Cannabis Capital Conference In Florida on April 16 and 17.
Tilray revealed in a Wednesday press release that those taking part in the study said cannabis had a “high degree of efficacy in alleviating their illness or symptoms,” with many emphasizing “a reduction in their use of prescription opioids, alcohol, tobacco, and other substances.”
“Our role in this initiative exemplifies our commitment to medical research, leading us one step closer to unlocking the full therapeutic potential of medical cannabis,” said José Tempero, Tilray’s medical director.
The latest results build on a growing body of research, which shows cannabis consumption among seniors is becoming more common. A recent study done at the University of Colorado Boulder, examined the effects of cannabis use in adults aged 60 to 88 with no history of alcohol or other substance use disorder. It showed that “low-dose, daily cannabis use after age 55 might effectively reduce the degenerative effects of chronic brain inflammation,” said Gary Wenk Ph.D., a scientist not involved in the study.
In addition, a recent New York Times report looked at the uncertainty and desperation that fuels senior cannabis use, and how many are turning to it as a last resort for various ailments. Dr. Aaron Greenstein, a geriatric psychiatrist said, “People are just desperate. They’re willing to try anything.”
Now read: Cannabis Boom: U.S. Leads World With 54M Consumers As Seniors, Not Youth, Drive Growth
The Benzinga Cannabis Capital Conference is returning to Florida, in a new venue in Hollywood, on April 16 and 17, 2024. The two-day event at The Diplomat Beach Resort will be a chance for entrepreneurs, both large and small, to network, learn and grow. Renowned for its trendsetting abilities and influence on the future of cannabis, mark your calendars – this conference is the go-to event of the year for the cannabis world.
Get your tickets now on bzcannabis.com – Prices will increase very soon!
